Shein Prepares for Hong Kong IPO After Global Listing Hurdles

As Shein expands its footprint in the global beauty market through its cosmetics brand SHEGLAM, its capital market trajectory is closely watched by retail and beauty competitors. A successful public listing would provide the fast-fashion giant with billions in fresh capital to scale its supply chain, challenge e-commerce rivals like Temu, and deepen its penetration into the beauty and lifestyle sectors.

Shein Group Ltd. is advancing preparatory work for a potential Hong Kong initial public offering (IPO), according to sources familiar with the matter. This move could cap a years-long, turbulent effort by the fast-fashion and beauty e-commerce giant to go public.

If the China Securities Regulatory Commission (CSRC) grants approval, Shein and its advisors could launch the IPO in the coming months. Recent discussions with the Chinese regulator have reportedly yielded more positive signals.

The company is considering raising several billion dollars, though the final figure will depend on its valuation. While preparations are underway, there is no firm timeline, and the listing could face further delays.

Shein has faced intense pressure from shareholders to slash its valuation to approximately $30 billion—a steep drop from the peak valuation of over $100 billion it commanded four years ago. A representative for Shein declined to comment, and the CSRC did not respond to requests for comment.

The pivot to Hong Kong follows unsuccessful attempts to list in New York and London. While Hong Kong’s benchmark stock index has dipped about 6% this year, its IPO market is showing signs of recovery, having raised nearly $35 billion in first-time share sales.

Shein’s initial US IPO plans stalled two years ago amid intense political and regulatory scrutiny over its supply chain and labor practices. A subsequent attempt in London was abandoned after Chinese regulators withheld approval. Although Shein relocated its headquarters to Singapore in 2021, it remains subject to CSRC oversight. Under Chinese regulations, any company with substantial operations or links to China must clear domestic regulatory reviews before listing abroad.

This regulatory bottleneck reflects a broader tightening of oversight for Chinese firms seeking capital. Even in domestic markets, companies face rigorous scrutiny; for instance, biomedical and consumer player Bioregen is pursuing an IPO on the Beijing Stock Exchange despite facing mounting losses in its consumer skincare pivot.

Conversely, the volatile public markets have driven some Asian consumer giants to retreat from the spotlight. Earlier this year, Japanese beauty giant Mandom delisted in a $900 million privatization deal to restructure away from public market pressures.

After years of downplaying its Chinese origins to market itself as a global brand, Shein has shifted its strategy. Founder Xu Yangtian has pledged to invest heavily in Guangdong province, the southern Chinese manufacturing hub that powers Shein's ultra-low-cost supply chain.

In addition to regulatory hurdles, Shein faces fierce competition from Temu, owned by PDD Holdings, in key Western markets. Rising tariffs and regulatory crackdowns on cross-border e-commerce have also squeezed margins. Shein’s prominent backers include IDG Capital, Mubadala Investment Co., Tiger Global Management, and HSG.